VANGUARD GROUP INC - 30 Jun 2025 SCHEDULE 13G/A Report for Bridgebio Pharma Inc Common Stock (BBIO)

Filing Manager
VANGUARD GROUP INC
Reporting Manager
The Vanguard Group
Symbol
BBIO
Shares outstanding
190M shares
Disclosed Ownership
16.5M shares
Ownership
8.68%
Form type
SCHEDULE 13G/A
Filing time
29 Jul 2025, 11:20:32 UTC
Date of event
30 Jun 2025

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
The Vanguard Group 8.68% 16.5M 0 186K Ashley Grim Head of Global Fund Administration